Effect of Endocervical-Specimen Adequacy on Detection of Chlamydia trachomatis by the APTIMA COMBO 2 Assay-Reference-Cited by-同舟云学术

Effect of Endocervical-Specimen Adequacy on Detection of Chlamydia trachomatis by the APTIMA COMBO 2 Assay

Published:2006-12 Issue:12 Volume:44 Page:4564-4565
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Rogers C. K.¹,Wood B. J.²,Rizzo P.²,Gaydos C. A.²

Affiliation:

1. Wyoming Public Health Laboratory, 517 Hathaway Bldg., 2300 Capitol Ave., Cheyenne, Wyoming 82002

2. Johns Hopkins University, 1159 Ross Bldg., 720 Rutland Ave., Baltimore, Maryland 21205

Abstract

ABSTRACT Six hundred one endocervical specimens were analyzed for Chlamydia trachomatis by the APTIMA Combo 2 assay and evaluated for columnar epithelial cell adequacy by direct fluorescent-antibody staining. With 5.5% positive adequate and 7.8% positive inadequate specimens ( P = 0.27), the study suggested no difference in positivity rates due to specimen adequacy when this amplified technology was used.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00981-06

Reference18 articles.

1. Beebe, J. L., K. A. Gershman, J. K. Kelley, D. Hagner, and P. Creede. 1999. How adequate is adequate for the collection of endocervical specimens for Chlamydia trachomatis testing? Sex. Transm. Dis.26:579-583.

2. Current methods of laboratory diagnosis of Chlamydia trachomatis infections

3. Centers for Disease Control and Prevention. 1993. Recommendations for the prevention and management of Chlamydia trachomatis infections, 1993. Morb. Mortal. Wkly. Rep.42:1-39.

4. Centers for Disease Control and Prevention. 2002. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections, 2002. Morb. Mortal. Wkly. Rep.51:1-40.

5. Chernesky, M. A. 1999. Nucleic acid tests for the diagnosis of sexually transmitted diseases. FEMS Immunol. Med. Microbiol.24:437-446.